Hyperopia Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Hyperopia Epidemiology Forecast Report Coverage

Expert Market Research's “Hyperopia Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of hyperopia. It projects the future incidence and prevalence rates of hyperopia cases across various populations. The study covers age, gender, and type as major determinants of the hyperopia population. The report highlights patterns in the prevalence of hyperopia over time and projects future trends based on multiple variables.

Hyperopia Understanding: Disease Overview

Hyperopia (farsightedness) is a common refractive error of the eye where distant objects are seen more clearly than near objects due to light focusing behind the retina. It is primarily caused by a shorter axial length or reduced refractive power of the cornea and lens. The condition affects both children and adults, with prevalence increasing with age-related changes. Hyperopia epidemiology shows significant variation across populations, influencing vision quality, reading ability, and daily functioning. It is often underdiagnosed in mild cases, especially in younger individuals.

Hyperopia Epidemiology Perspective

The hyperopia epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the hyperopia epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hyperopia and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the American Academy of Ophthalmology, hyperopia prevalence in infants is common in early life, with most full-term newborns mildly affected. Prevalence declines from 4-9% at 6-9 months to approximately 3.6% at 12 months, consistent with normal visual maturation and the emmetropization process during early ocular development.
• As per Eye Health Central and updated global analyses, global hyperopia prevalence varies widely by age and region, affecting approximately 8.4% of children at age six, declining to 1% by age fifteen, while adult prevalence rises from 9.9% in younger adults to 14.9% in older populations.
• According to the Multi-Ethnic Pediatric Eye Disease Study, pediatric hyperopia by ethnicity reveals significant demographic variability, affecting 26.9% of Hispanic, 25% of non-Hispanic White, 20.8% of African American, and 13% of Asian American children, highlighting the importance of ethnicity-specific screening strategies within multiethnic pediatric populations across the United States.
• According to the Samuel Otabor Wajuihian, et al., 2021, age-related farsightedness increases notably after age 40, with females consistently demonstrating higher prevalence rates than males across all age groups.
• According to the American Academy of Ophthalmology, uncorrected hyperopia complications carry negligible mortality but significant morbidity. Hyperopia exceeding +3.50 diopters increases strabismus risk up to 13-fold by age four. Pooled pediatric data further confirm that moderate-to-high hyperopia (≥4.0 diopters) affects 3.2% of children aged 6-72 months, reinforcing the critical value of early detection and prompt correction.

• 

  Read more about this report - Request a Free Sample

Country-wise Hyperopia Epidemiology Segment

The hyperopia epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The United States and the United Kingdom together offer a well-documented representation of country-wise hyperopia epidemiology in high-income nations. According to the American Academy of Ophthalmology and Eye Health Central, in the United States, approximately 10% of the population, nearly 14 million individuals, are affected, with prevalence rising from 9.9% in adults aged 20-39 to 14.9% in those aged 60 and older. In Europe, prevalence is estimated at 23.1% of the population, according to Eye Health Central. In Japan, hyperopia prevalence reaches around 20% in older adults, whereas India reports a lower overall prevalence (approximately 12–18% regionally in Asia) due to a higher myopia burden, as per Eye Health Central, highlighting distinct regional epidemiological patterns.

Hyperopia: Treatment Overview

Treatment of hyperopia focuses on correcting refractive error to improve near vision and reduce eye strain. The primary management includes prescription convex corrective lenses (glasses or contact lenses), which adjust light focus onto the retina. Refractive surgery options such as LASIK and photorefractive keratectomy (PRK) are considered in eligible adults for long-term correction. Pediatric cases may require early optical correction to prevent amblyopia. Advances in refractive error management and ophthalmic diagnostics have improved treatment precision, enhancing visual outcomes and quality of life across affected populations globally.

Key Questions Answered

• What are the key findings of hyperopia epidemiology in the 8 major markets?
• What will be the total number of patients with hyperopia across the 8 major markets during the forecast period?
• What was the country-wise hyperopia epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of hyperopia patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of hyperopia during the forecast period of 2026-2035?
• What are the currently available treatments for hyperopia?
• What are the disease risks, signs, symptoms, and unmet needs of hyperopia?

Scope of the Hyperopia Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hyperopia based on several factors.
• Hyperopia Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The hyperopia report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Refractive Surgery Devices Market

Refractive Errors Pipeline Analysis